ESP-INOCA:在怀疑心肌缺血和非阻塞性冠状动脉的患者中预后分层的国家多中心注册表的逻辑和设计
Eva Rumiz1, Fernando Rivero2, Ainhoa Pérez3
1Cardiology Department, Consorcio Hospital General Universitario, Universitat de València, Valencia, Spain; Cardiology Department, Hospital QuironSalud, Valencia, Spain.
International journal of cardiology
|August 31, 2025
概括
本研究研究的是患有缺血但没有阻塞性冠状动脉疾病 (INOCA) 的患者. 它的目的是通过全国性的注册来确定不同INOCA内型的流行率和长期结果.
科学领域:
- 心脏病学
- 血管医学
- 诊断测试
背景情况:
- 阻塞性冠状动脉疾病 (CAD) 是心肌缺血的一个常见原因.
- 然而,多达50%的心痛和缺血患者的冠状动脉没有阻塞 (INOCA).
- INOCA是异质的,经常被诊断不足和治疗不足.
研究的目的:
- 确定不同INOCA内型的流行率.
- 评估这些INOCA内型的长期临床结果.
- 改善风险分层和对INOCA的理解.
主要方法:
- 一个前性的,纵向的全国性注册表 (ESP-INOCA).
- 包括疑似心肌缺血且没有阻塞性心脏病的患者,接受冠状动脉血管学和冠状动脉功能检测 (CFT).
- 评估内皮独立的血管功能 (冠状动脉流量储备,微血管抵抗指数) 和冠状动脉血管障碍 (乙胆测试).
主要成果:
- 该注册包括患有慢性冠状动脉综合征和疑似心肌缺血症的患者.
- 进行冠状动脉功能测试以评估血管功能和血管运动障碍.
- 主要结局是1年内主要心血管不良事件的组合.
结论:
- 这份登记册将为INOCA内型的长期预后提供洞察力.
- 这些发现将有助于改善INOCA患者的风险分层.
- 预计将对这种异构的临床实体有更好的理解.
相关概念视频
Acute Coronary Syndrome III: Diagnostic Studies
23
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23
Ischemic Heart Disease: Overview
1.4K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K
Coronary Artery Disease I: Introduction
54
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
54
Coronary Artery Disease IV: Preventive Measures
32
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
32
Coronary Artery Disease III: Clinical Manifestations
31
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
31
Coronary Artery Disease V: Interprofessional Care
30
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
30


